The extracellular thyrotropin receptor domain is not a major candidate for mutations in toxic thyroid nodules

Thyroid

Volumn 8, Issue 11, 1998, Pages 997-1001

  Führer, Dagmar ^a   Kubisch, Constanze ^a   Scheibler, Ursula ^b   Lamesch, Peter ^a   Krohn, Knut ^a   Paschke, Ralf ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Department of Surgery ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; NUCLEIC ACID BASE; PROLINE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THREONINE; THYROTROPIN RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENETIC POLYMORPHISM; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SOMATIC MUTATION; THYROID NODULE;

EID: 0031773273     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.997     Document Type: Article

References (34)

1. Paschke R, Ludgate M 1997 The thyrotropin receptor in thyroid disease. N Engl J Med 337:1675-1681.
2. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G 1993 Somatic mutations in the thy rotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651.
3. Führer D, Holzapfel HP, Wonerow P, Scherbaum WA,Paschke R 1997 Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885-3891.
4. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P,Van Vliet G, Costagliola S, Rodien P, Dumont JE, Vassart G1997 Diversity and prevalence of somatic mutations in thethyrotropin receptor and Gs α genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 82:2695-2701.
5. Holzapfel HP, Führer D, Wonerow P, Weinland G,Scherbaum WA, Paschke R 1997 Identification of constitutively activating somatic thyrotropin receptor mutations in asubset of toxic multinodular goiters. J Clin Endocrinol Metab82:3885-3891.
6. Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G,Parma J 1997 Two autonomous nodules of a patient withmultinodular goiter harbor different activating mutationsof the thyrotropin receptor. J Clin Endocrinol Metab 82:306-308.
7. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J,Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J,Vassart J 1994 Germline mutations in the thyrotropin receptor gene cause nonautoimmune autosomal dominant hyperthyroidism. Nature Genetics 7:396-401.
8. Tonacchera M, Van Sande J, Cetani F, Swillens S, SchvartzC, Winiszewski P, Portmann L, Dumont JE, Vassart G, ParmaJ 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomaldominant toxic thyroid hyperplasia. J Clin Endocrinol Metab81:547-554.
9. Führer D, Wonerow P,Willgerodt W, Scherbaum W, PaschkeR 1997 Identification of a new TSH receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234-4238.
10. Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E,Jameson JL, Dumont JE, Vassart G 1995 Brief report: Congenital hyperthyroidism caused by a mutation in the thyrotropin receptor gene. N Engl J Med 332:150-154.
11. DeRoux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E, Misrahi M 1996 A neomutation of the thyroid stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81:2023-2026.
12. Esapa C, Betts P, Kendall-Taylor P, Harris PE 1996 A novelTSH receptor mutation in an infant with thyrotoxicosis [abstract] J Endocrinol Invest 19(suppl 6):71.
13. Holzapfel HP, Wonerow P, Von Pettrikowski W, HenschenM, Scherbaum WA, Paschke R 1997 Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in thethyrotropin receptor gene. J Clin Endocrinol Metab 82:3879-3884.
14. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K,Feichtinger H, Duh QY, Clark OH, Kawasaki F, Bourne HR1990 Two G protein oncogenes in human endocrine tumors.Science 249:655-659.
15. O'SuIlivan C, Barton CM, Staddon SL, Brown CL, LemoineNR 1991 Activating point mutations of the gsp oncogene inhuman thyroid adenomas. Mol Carcinogr 4:345-349.
16. Russo D, Arturi F, Wicker R, Chazenbalk GD, SchlumbergerM, Du Villard JA, Caillou B, Monier R, Rapoport B, FilettiS, Sudrez HG 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 80:1347-1351.
17. Tanaka K, Nagayama Y, Takeshita A, Namba H, YamashitaS, Niwa M, Nagataki S 1996 Low incidence of the stimulatory G protein alpha-subunit mutations in a autonomouslyfunctioning thyroid adenomas in Japan. Thyroid 6:195-199.
18. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G1994 Identification and functional characterization of twonew somatic mutations causing constitutive activation of theTSH receptor in hyperfunctioning autonomous adenomas ofthe thyroid. J Clin Endocrinol Metab 79:1785-1789.
19. Porcellini A, Ciullo I, Laviola L, Amabile G, Frenzi G, Avvedimento VE 1994 Novel mutations of thyrotropin receptorgene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 79:657-661.
20. 2+-cascades. Mol Endocrinol 9:725-733.
21. Takeshita A, Nagayama Y, Yokoyama N, Ishikawa N, Ito K,Yamashita T, Obara T, Murakami Y, Kuma K, Takamatsu J,Ohsawa N, Nagataki S 1995 Rarity of oncogenic mutations inthe thyrotropin receptor of autonomously functioning thyroidnodules in Japan. J Clin Endocrinol Metab 80:2607-2611.
22. Russo D, Arturi F, Suarez HG, Schlumberger M, Du VillardJA, Crocetti U, Filetti S 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 81:1548-1551.
23. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL, RoddC 1997 Congenital hyperthyroidism caused by a solitary toxicadenoma harboring a novel somatic mutation (serin 281 ≥isoleucin) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100:1634-1639.
24. Spiegel AM 1996 Genetic basis of endocrine disease. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 81:2434-2442.
25. Krohn K, Führer D, Holzapfel HP, Paschke R 1998 Clonalorigin of toxic thyroid nodules with constitutively activatingTSH receptor mutations. J Clin Endocrinol Metab 83:130-134.
26. Pollak MR, Brown EM, Estep HL, Me Laine PN, Kifor O,Park J, Hebert SC, Seidman CE, Seidman JG 1993 Autosomal dominant hypocalcemia caused by a Ca 2+-sensing receptor gene mutation. Nat Gent 8:303-307.
27. De Roux N, Misrahi M, Chatelain N, Gross B, Milgrom E1996 Microsatellites and PCR primers for genetic studies andgenomic sequencing of the human TSH receptor gene. MolCell Endocrinol 117:253-256.
28. Rosenthal A, Coutelell O, Craxton M 1993 Large-scale production of DANN sequencing templates by microtitre formatPCR. Nucleic Acids Res 21:173-174.
29. Sunthornthepvarakul T, Hayashi Y, Refetoff S 1994 Polymorphism of a variant human thyrotropin receptor (hTSHR)gene. Thyroid 4:147-149.
30. Tonacchera M, Cetani F, Costagliola S, Van Sande J, RefetoffS, Vassart G 1996 Functional characteristics of a variant thyrotropin receptor. Eur J Biochem 238:490-494.
31. Minuto F, Barreca A, Del Monte P, Cariola G, Torre GC,Giordano G 1989 Immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding protein content in human thyroid tissue. J Clin Endocrinol Metab 68:621-626.
32. Williams DW, Williams ED, Wynford-Thomas D 1989 Evidence for autocrine production of IGF-I in human thyroidadenomas. Mol Cell Endocrinol 61:139-143.
33. Tang WJ, Gilman AG 1992 Adenylylcyclases. Cell 70:869-872.
34. α-1 in autonomous adenoma. Proc Natl Acad Sci USA90:1609-1613.